Back

Risk of worsening heart failure and all-cause mortality following mRNA covid-19 vaccination in patients with heart failure: a Danish nationwide real-world safety study

26 August 2022 (08:15 - 09:00)
Organised by:
Congress Presentation Part of: Covid-19 and heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Ms Caroline Sindet-Pedersen

Gentofte Hospital - Copenhagen University Hospital, Hellerup (Denmark)

7 More presentations in this session

Presentation thumbnail
Monitoring of the lung fluid status in hospitalized COVID-19 patients for predicts outcome. Results of the IMPEDANCE-Corona Trial
Professor M. Kleiner Shochat (Hadera, IL)
Abstract Slides
Presentation thumbnail
Factors of persistent limited exercise tolerance in patients after COVID-19 with normal left ventricular ejection fraction
Miss K. Gryglewska-Wawrzak (Lodz, PL)
Abstract Slides
Presentation thumbnail
The impact of pre-existing chronic heart failure on the intensive care treatment and outcome of old intensive care patients suffering from COVID-19
Doctor R. Bruno (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
History of heart failure and chronic kidney disease and the risk for all-cause death after COVID-19 during the three first waves in comparison to influenza outbreaks in Sweden.
Doctor V. Ritsinger (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Prognostic value of brain natriuretic peptide in COVID-19 with or without acute heart failure
Doctor M. Bergami (Bologna, IT)
Abstract Slides

Access the full session

Session thumbnail
Covid-19 and heart failure

The Event

Event poster

ESC Congress 2022

26 August 2022 08:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources